Rate My Professor Livia Carvalho

Carvalho's research centers on precision medicine in mental health, particularly immunophenotyping depression to inform treatment decisions, stratify patients, and identify novel anti-inflammatory targets for drug discovery and repositioning. Her translational work integrates laboratory-based experiments, clinical trials, and epidemiological cohorts to elucidate mechanisms linking peripheral immune activation, neuroendocrine disturbances, and mental illnesses like depression, including associations with physical conditions such as coronary heart disease and chronic kidney disease. Key publications include 'Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort' (Molecular Psychiatry, 2020), 'DHEA and response to antidepressant treatment: A Mendelian Randomization analysis' (Journal of Psychiatric Research, 2024), 'Work hours, weekend working, nonstandard work schedules and sleep quantity and quality: findings from the UK household longitudinal study' (BMC Public Health, 2024), and 'A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease' (Psychological Medicine, 2023). With an h-index of 36 on Scopus, her contributions have advanced understanding of inflammation's role in psychiatric disorders. She is Associate Editor of Brain, Behaviour, and Immunity and has received Young Investigator Awards from NARSAD, the European Neuropsychopharmacology Society, the British Association for Psychopharmacology, and the American Psychosomatic Society.